BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 24, 2008
 |  BC Week In Review  |  Company News  |  Deals

CardioVascular BioTherapeutics, Cardio Neo-Genesis L.P. deal

CardioVascular will receive up to $15 million from Cardio Neo-Genesis to fund clinical development of CardioVascular's CVBT-141H to treat coronary heart disease (CHD). In...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >